- Home
- ONL vs WHWK Comparison
ONL vs WHWK Comparison
Compare ONL & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONL | WHWK |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.5M | 95.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ONL | WHWK |
|---|---|---|
| Price | $2.26 | $2.66 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 308.1K | 179.5K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $149,775,000.00 | $14,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.46 | $1.39 |
| 52 Week High | $4.25 | $3.81 |
Technical Indicators
Market Signals| Indicator | ONL | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 60.70 |
| Support Level | $1.97 | $2.40 |
| Resistance Level | $2.28 | $2.85 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 93.06 | 69.67 |
Price Performance
Historical ComparisonAbout ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.